[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":13554000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3153000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":110000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":2207000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q1_USD":31000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2088000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_1_Q1_USD":1000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":39246000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":34021000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":173000000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":247000.0,"LongTermDebtCurrent_0_Q1_USD":1000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":230000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-18980000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":434722000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1961000.0,"OtherAssetsNoncurrent_0_Q1_USD":4317000.0,"OperatingLeasesRentExpenseNet_1_Q1_USD":300000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":183124000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":7886000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff_1_Q1_USD":0.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":-160000.0,"RestrictedCashNoncurrent_0_Q1_USD":210000.0,"RestrictedCash_0_Q1_USD":210000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":11274000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":230000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.056,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2200000.0,"OperatingLeasePayments_1_Q1_USD":200000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":1800000.0,"NonoperatingIncomeExpense_1_Q1_USD":990000.0,"OperatingLeaseLiability_0_Q1_USD":2217000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":739000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":706000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":728000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":749000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":772000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":527000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":2743000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":59000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":526000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":2200000.0,"LongTermDebtNoncurrent_0_Q1_USD":6500000.0,"InterestAndOtherIncome_1_Q1_USD":1119000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":27461000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":247000.0,"LiabilitiesCurrent_0_Q1_USD":14554000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":226462000.0,"Liabilities_0_Q1_USD":23261000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1482000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":7625000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.42,"CommonStockValue_0_Q1_USD":5000.0,"CommonStockSharesOutstanding_0_Q1_shares":45430000.0,"CommonStockSharesIssued_0_Q1_shares":45430000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":33811000.0,"AssetsCurrent_0_Q1_USD":221130000.0,"Assets_0_Q1_USD":226462000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":5368000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":561000.0,"AccountsPayableCurrent_0_Q1_USD":2453000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-19822000.0,"NetIncomeLoss_1_Q1_USD":-19210000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":511000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4164000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-2391000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":92000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":247000.0,"ShareBasedCompensation_1_Q1_USD":3153000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":12575000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":897000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"OperatingExpenses_1_Q1_USD":20200000.0,"InterestExpense_1_Q1_USD":144000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":45411000.0,"StockholdersEquity_0_Q1_USD":203201000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-232087000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":805000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"TenantImprovements_0_Q1_USD":1000000.0,"Ticker":"KURA","CIK":"1422143","name":"KURA ONCOLOGY, INC.","OfficialName":"Kura Oncology Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1071823749.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200504"}]